LNSR (STOCKS)
LENSAR, Inc. Common Stock
$5.920000
+0.220000 (+3.86%)
Prev close: $5.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Nicholas T. Curtis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $71.12M
- Employees
- 140
- P/E (TTM)
- -2.04
- P/B (TTM)
- -2.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $58.44M |
| Benefits Costs and Expenses | $92.72M |
| Cost Of Revenue | $31.31M |
| Costs And Expenses | $92.72M |
| Gross Profit | $27.12M |
| Operating Expenses | $51.70M |
| Selling, General, and Administrative Expenses | $45.16M |
| Research and Development | $5.62M |
| Other Operating Expenses | $921.00K |
| Operating Income/Loss | -$24.58M |
| Income/Loss From Continuing Operations After Tax | -$34.28M |
| Income/Loss From Continuing Operations Before Tax | -$34.28M |
| Net Income/Loss | -$34.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | -$10.00K |
| Basic Earnings Per Share | -$2.87 |
| Diluted Earnings Per Share | -$2.87 |
| Basic Average Shares | 11,958,000 |
| Diluted Average Shares | 11,958,000 |
| Assets | $71.43M |
| Current Assets | $46.77M |
| Inventory | $21.52M |
| Other Current Assets | $25.25M |
| Noncurrent Assets | $24.66M |
| Fixed Assets | $505.00K |
| Other Non-current Assets | $24.15M |
| Liabilities | $83.67M |
| Current Liabilities | $40.57M |
| Accounts Payable | $18.98M |
| Wages | $5.05M |
| Other Current Liabilities | $16.54M |
| Noncurrent Liabilities | $43.09M |
| Equity | -$26.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$26.02M |
| Temporary Equity | $13.78M |
| Liabilities And Equity | $71.43M |
| Net Cash Flow From Operating Activities | -$14.83M |
| Net Cash Flow From Operating Activities, Continuing | -$14.83M |
| Net Cash Flow From Investing Activities | $1.28M |
| Net Cash Flow From Investing Activities, Continuing | $1.28M |
| Net Cash Flow From Financing Activities | $10.26M |
| Net Cash Flow From Financing Activities, Continuing | $10.26M |
| Net Cash Flow | -$3.29M |
| Net Cash Flow, Continuing | -$3.29M |
| Comprehensive Income/Loss | -$34.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.28M |
| Other Comprehensive Income/Loss | -$2.00K |